FDA.reportPublic FDA data

Blujepa 750 MG (equivalent to gepotidacin mesylate dihydrate 970.96 MG) Oral Tablet

RxCUI
2709224
RxNorm name
Blujepa 750 MG (equivalent to gepotidacin mesylate dihydrate 970.96 MG) Oral Tablet
Display name
Blujepa 750 MG (equivalent to gepotidacin mesylate dihydrate 970.96 MG) Oral Tablet
Full name
Blujepa 750 MG (equivalent to gepotidacin mesylate dihydrate 970.96 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BlujepaGEPOTIDACINGlaxoSmithKline LLC80b57cfe-7819-4d95-a57d-014af42f118d2026-02-10Warnings, Adverse reactionsExact identifier
rxcui: 2709224

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
80b57cfe-7819-4d95-a57d-014af42f118dBLUJEPA 750 MG Oral Tablet [PSN] · gepotidacin 750 MG Oral Tablet [Blujepa] [SBD] · Blujepa 750 MG (equivalent to gepotidacin mesylate dihydrate 970.96 MG) Oral Tablet [SY] · Blujepa 750 MG Oral Tablet [SY]43These highlights do not include all the information needed to use BLUJEPA safely and effectively. See full prescribing information for BLUJEPA. BLUJEPA (gepotidacin) tablets, for oral use Initial U.S. Approval: 202520260210